SeaStar Medical Holding (ICU) Interest Coverage Ratio (2022 - 2026)
SeaStar Medical Holding's (ICU) quarterly Interest Coverage Ratio came in at 600.5 in Q1 2026, down 72.83% YoY from 2210.03 in Q1 2025, and down 636816.26% on a QoQ basis from 0.09 in Q4 2025.
SeaStar Medical Holding (ICU) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 5 years of Interest Coverage Ratio data on file, last reported at 600.5 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 72.83% year-over-year to 600.5 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 213.46 (down 376.0% YoY) and the FY2025 annual result came in at 0.38, up 39.18% from the prior year.
- Interest Coverage Ratio retreated to 600.5 in Q1 2026, from 0.09 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.09 in Q4 2025 to a low of 1286.0 in Q4 2022.
- A 5-year average of 172.87 and a median of 16.52 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio sank 1220.11% — and 2025, when it surged 99.94%.
- Tracing ICU's Interest Coverage Ratio over 5 years: stood at 1286.0 in 2022, then soared by 99.06% to 12.04 in 2023, then slumped by 1220.11% to 158.9 in 2024, then surged by 99.94% to 0.09 in 2025, then plunged by 636816.26% to 600.5 in 2026.
- The last three Interest Coverage Ratio figures came in at 600.5 (Q1 2026), 0.09 (Q4 2025), and 195.11 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 1.42 |
| 10 | SeaStar Medical Holding | 14.09 Mn | 7.09 Mn | 561,000.00 | -473.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -473.88 |
| Mar 31, 2026 | -600.50 |
| Dec 31, 2025 | -0.09 |
| Jun 30, 2025 | -195.11 |
| Mar 31, 2025 | -347.45 |
| Dec 31, 2024 | -158.90 |
| Sep 30, 2024 | -16.38 |
| Jun 30, 2024 | -56.94 |
| Mar 31, 2024 | -27.62 |
| Dec 31, 2023 | -12.04 |
| Sep 30, 2023 | -13.13 |
| Jun 30, 2023 | -16.67 |
| Mar 31, 2023 | -9.02 |
| Dec 31, 2022 | -1,286.00 |
| Sep 30, 2022 | -14.38 |
| Jun 30, 2022 | -6.87 |
| Mar 31, 2022 | -4.80 |